Status:
UNKNOWN
Effect of Menstrual Cycle on Traumatic Systemic Response
Lead Sponsor:
Kocaeli University
Conditions:
Systemic Inflammatory Response Syndrome
Eligibility:
FEMALE
Phase:
NA
Brief Summary
It is aimed to evaluate pathophysiology of systemic responses to trauma via using interleukin (IL) -1 and IL-6 levels and determining timing of surgery through phases of menstrual cycle.
Detailed Description
89 female breast cancer patient who underwent modified radical mastectomy included into study. Menstrual history and hormone levels were used to determine menstrual phase: luteal, follicular, and othe...
Eligibility Criteria
Inclusion
- female patients
- who underwent modified radical mastectomy for breast cancer
- who signed informed consent forms
Exclusion
- For premenopausal patients taking oral contraceptives
- for postmenopausal patients taking hormone replacement therapy.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2018
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT03283345
Start Date
June 1 2008
End Date
November 1 2018
Last Update
September 18 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.